Validation Package Review in Forensic Toxicology

This page is a case-review checklist for evaluating a laboratory’s validation package and the records connecting that validation to a particular result. For the broader technical overview of validation characteristics and terminology, start with Method Validation in Forensic Toxicology. Here, the narrower question is whether the validation package actually covers the specimen, analyte, concentration range, instrument, method version, processing rules, reporting purpose, and result being offered in the case.

ANSI/ASB Standard 036, Standard Practices for Method Validation in Forensic Toxicology, establishes minimum validation practices for targeted forensic toxicology methods used in postmortem, human-performance, court-ordered, employment, and general forensic toxicology. The AAFS Standards Board explains that the purpose of validation is to establish confidence and reliability by demonstrating that the method is fit for its intended use. See the official ANSI/ASB 036 resource.

What should a forensic toxicology validation establish?

A defensible validation should answer the analytical questions that could change the reported conclusion. Those questions differ somewhat for screening, qualitative identification, and quantitative analysis, but they commonly include whether the method identifies the intended analyte selectively, performs acceptably across the relevant concentration range, resists interference and carryover, remains reliable in the tested matrix, and produces results with acceptable precision and bias.

Validation question	Why it matters in case review	Related technical guide
Is the signal selective for the reported analyte?	Coeluting drugs, metabolites, isomers, isobars, matrix components, or in-source fragments can undermine identification.	Selectivity and interference
Does the calibration model fit the validated range?	A model can look visually acceptable while producing concentration-dependent bias, especially near the low end.	Calibration weighting
Does the biological matrix alter response?	Ion suppression or enhancement can change analyte and internal-standard response and may not be uniform across specimens.	Matrix effects
Can a high preceding sample contaminate a later injection?	Carryover is especially important when a low-level positive follows a high concentration in the same sequence.	LC-MS/MS carryover
Is the analyte stable under actual storage and processing conditions?	Loss, conversion, or degradation can occur before extraction or after preparation.	Specimen stability and autosampler stability
What does the method support near its reporting limit?	Detection, identification, quantitation, and a legal or administrative cutoff are different concepts.	LOD, LOQ and reporting limits
Can diluted or above-range specimens be reported reliably?	Dilution can introduce additional uncertainty or fall outside the demonstrated procedure.	Repeat analysis and replicate agreement
Does routine batch QC show the method was operating acceptably that day?	Validation demonstrates capability; contemporaneous QC addresses whether the method was under control for the analytical batch.	Failed QC and batch review

Validation is not the same as routine quality control

Validation and quality control answer related but different questions. Validation asks whether the procedure can perform adequately for its intended purpose. Routine QC asks whether the validated method was operating within defined criteria during the particular analytical batch. ANSI/ASB Standard 054 establishes minimum requirements for quality-control programs, including calibrators, controls, performance expectations, and monitoring. See the official ANSI/ASB 054 resource.

A method can have an excellent historical validation and still produce a questionable case result if the relevant batch shows failed controls, abnormal internal-standard response, unacceptable carryover, manual processing that departed from procedure, or another unresolved analytical problem. Conversely, passing controls do not retroactively establish that an unvalidated matrix, analyte, range, or processing change is fit for purpose.

Fit for purpose is analyte-, matrix-, and use-specific

Forensic laboratories often use a single platform to test many compounds and specimen types. That does not mean every analyte has identical performance. A case review should identify the exact analyte, specimen matrix, calibration range, reporting purpose, and version of the method used on the date of analysis.

For example, a method validated for quantitative analysis in blood should not automatically be assumed to have identical quantitative performance in urine, vitreous humor, liver homogenate, oral fluid, or a nonstandard postmortem matrix. Likewise, adding a new analyte, changing extraction chemistry, changing chromatographic conditions, replacing an instrument platform, changing data-processing rules, or materially changing the calibration model may require documented verification or additional validation.

Identification and quantitation should be reviewed separately

In LC-MS/MS casework, a number can appear precise even when the underlying identity evidence is weak. Reviewers should therefore separate two questions: was the compound identified according to the laboratory’s validated criteria, and if so, was its concentration quantified reliably?

Identification commonly depends on evidence such as retention behavior, diagnostic transitions, ion-ratio or other relative-response criteria, reference standards, and interference review. Quantitation adds separate questions involving calibration, weighting, range, bias, precision, matrix effects, internal standards, dilution, and measurement uncertainty. See LC-MS/MS identification criteria and measurement uncertainty near cutoffs.

Internal standards help, but they do not cure every analytical problem

Stable-isotope internal standards are powerful tools for compensating for extraction variability, injection variability, and some matrix-related response changes. Their performance still has to be evaluated. An internal standard cannot prove analyte identity, correct an unresolved chromatographic interference merely because both peaks are present, reverse specimen degradation, or guarantee that carryover did not occur. A labeled analogue may also fail to compensate fully if it does not behave sufficiently like the target analyte under the method conditions. See Stable-Isotope Internal Standards in Forensic LC-MS/MS.

Manual data processing belongs in the validation and audit-trail review

Automated integration is not infallible, and manual re-integration can sometimes be scientifically justified. The key questions are whether the laboratory has validated or otherwise controlled its processing rules, whether comparable samples were treated consistently, whether the change is preserved in the audit trail, and whether the reprocessed result still satisfies identification and QC requirements. See Manual Peak Re-Integration in Forensic Toxicology.

What records should be requested in a case?

A meaningful validation review usually requires more than the final laboratory report. Depending on the issue, useful records can include:

• the validation summary and underlying validation data for the method version used;
• the written analytical procedure and revision history in effect on the test date;
• calibration data, regression model, weighting, residuals, and acceptance criteria;
• positive controls, negative controls, blanks, and carryover checks;
• internal-standard responses and acceptance criteria;
• chromatograms, mass-spectral or transition data, integration records, and audit trails;
• sequence order, preceding high-concentration samples, reinjections, repeats, and re-extractions;
• reference-material certificates and preparation records;
• stability data relevant to storage, freeze-thaw exposure, extracts, and autosampler time;
• deviation, corrective-action, maintenance, and troubleshooting records relevant to the batch.

The broader Toxicology Laboratory Records: Evidence Review Checklist provides a structured starting point.

A practical hierarchy for reviewing method reliability

1. Define the reported proposition. Is the laboratory asserting presence, concentration, impairment, exposure timing, cause of death, or another conclusion?
2. Identify the exact method and version. Match the case date to the procedure and validation in force at that time.
3. Confirm scope. Determine whether the analyte, matrix, range, and intended use were actually covered.
4. Review validation characteristics relevant to the result. Focus on the failure modes that could change the conclusion in this case.
5. Review batch performance. Validation history does not substitute for contemporaneous QC and sequence review.
6. Review the raw analytical evidence. Chromatography, identification criteria, integration, internal standards, repeats, and audit trails can reveal issues that a certificate or final report does not show.
7. Separate analytical reliability from interpretation. A valid concentration does not automatically prove dose, timing, impairment, toxicity, or causation.

Current professional context

A 2025 Journal of Analytical Toxicology best-practices review on postmortem forensic toxicology emphasizes that method validation should cover the analytical workflow, including sample preparation, instrumental parameters, data processing, and review, and should be integrated with quality assurance and current consensus standards. See Application of professional best practices in postmortem forensic toxicology.

Bottom line: the statement “the method was validated” is the beginning of a reliability inquiry, not the end. A defensible forensic review connects the validation evidence to the exact analyte, matrix, concentration range, instrument, processing rules, batch performance, and proposition being offered in the case.